Phase I/II study of an anti-CD20-interleukin-2 immunocytokine DI-Leu16-IL2 in patients with relapsed b-cell lymphoma (NHL).Frederick Lansigan,Ryotaro Nakamura,Donald Quick,Daniel Vlock,Andrew Antony Raubitschek,Stephen D Gillies,Veronika BachanovaJournal of Clinical Oncology(2016)引用 6|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要